Eli Lilly shares are trading higher after Morgan Stanley raised its price target on the stock from $805 to $950.
Portfolio Pulse from Benzinga Newsdesk
Eli Lilly's stock price increased following Morgan Stanley's decision to raise its price target from $805 to $950.
February 16, 2024 | 4:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Eli Lilly's stock price is likely to experience a short-term increase following Morgan Stanley's raised price target from $805 to $950.
Morgan Stanley's decision to raise the price target for Eli Lilly from $805 to $950 signals a strong bullish outlook on the stock, likely influencing investor sentiment and driving up the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100